Michael B Fergione

Title: Michael B Fergione: Innovator in Pharmaceutical Compositions

Introduction

Michael B Fergione is a notable inventor based in Stonington, CT (US). He has made significant contributions to the field of pharmaceuticals, holding 2 patents that focus on innovative drug formulations and delivery systems. His work has implications for treating various medical conditions, showcasing his expertise and dedication to improving healthcare.

Latest Patents

Fergione's latest patents include a "Pharmaceutical compositions of atorvastatin," which describes a wet granulated pharmaceutical composition that combines atorvastatin with specific additives to enhance its effectiveness. This composition is designed to treat conditions such as hypercholesterolemia, osteoporosis, and Alzheimer's disease. Another significant patent is the "Hydrogel-driven layered drug dosage form," which details a controlled release dosage form for sertraline. This innovative dosage form is engineered to release the drug at specific rates, ensuring optimal therapeutic effects over time.

Career Highlights

Throughout his career, Michael B Fergione has worked with prominent companies in the pharmaceutical industry, including Warner-Lambert Company and Pfizer Corporation. His experience in these organizations has contributed to his understanding of drug development and innovation.

Collaborations

Fergione has collaborated with notable colleagues such as Barbara A Johnson and Kenneth Craig Waterman. These partnerships have likely enriched his research and development efforts, leading to successful patent applications.

Conclusion

Michael B Fergione's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical treatments. His patents reflect a deep understanding of drug formulation and delivery, positioning him as a valuable inventor in the healthcare sector.